Literature DB >> 2345914

Diagnosis of typhoid fever in Nigeria: misuse of the Widal test.

M A Onuigbo1.   

Abstract

In the last 2 years, there has been public panic across Nigeria about an epidemic of a 'killer' febrile disease, purportedly typhoid fever. The evidence for this epidemic is reviewed in the light of appropriate diagnosis of typhoid fever. All the patients were diagnosed as typhoid fever, primarily based on Widal test results. Investigations in the hospital of 15 patients confirmed malaria in 70% who, though failing to respond to chloroquine, promptly responded to treatment with Fansidar (sulfadoxine + pyrimethamine). Fever in the remaining 30%, without evidence of malaria and who failed to respond to chloroquine, Fansidar and antibacterials including chloramphenicol, remitted spontaneously. The merits and limitations of the Widal test are discussed. It is concluded that diagnosis of typhoid fever by the Widal test alone is prone to error, and that any claims of a typhoid fever epidemic in Nigeria remain mere conjecture. Misuse of the Widal test and, subsequently, misuse of the antibiotic chloramphenicol, should be very strongly condemned.

Entities:  

Mesh:

Year:  1990        PMID: 2345914     DOI: 10.1016/0035-9203(90)90404-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  False positive widal reaction in high-titer disseminated BCG infection.

Authors:  A Skoutelis; G Dimitrakopoulos; H Bassaris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

2.  Bacteremia Among Febrile Patients Attending Selected Healthcare Facilities in Ibadan, Nigeria.

Authors:  Oluwafemi Popoola; Aderemi Kehinde; Veronica Ogunleye; Oluwafemi J Adewusi; Trevor Toy; Ondari D Mogeni; Eunice O Aroyewun; Sarah Agbi; Olukemi Adekanmbi; Akinlolu Adepoju; Sufiyan Muyibi; Ini Adebiyi; Oluseyi O Elaturoti; Chukwuemeka Nwimo; Hadizah Adeoti; Temitope Omotosho; Olabisi C Akinlabi; Paul A Adegoke; Olusoji A Adeyanju; Ursula Panzner; Stephen Baker; Se Eun Park; Florian Marks; Iruka N Okeke
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.